Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site




ABBVIE INC. (ABBV)

The QuantWave forecast for ABBV abbvie inc.

ABBVIE INC. is a pharmaceutical company that specializes in research and development of advanced therapies in the healthcare sector. With a focus on discovering, developing, and delivering innovative solutions, ABBVIE aims to improve the lives of people suffering from various diseases and medical conditions. The company is known for its expertise in areas such as immunology, neuroscience, and oncology. ABBVIE has a strong global presence and collaborates with healthcare professionals, scientists, and partners worldwide to drive cutting-edge advancements in medicine. With a commitment to patient-centric approaches, ABBVIE strives to address unmet medical needs through its transformative products and therapies.
The graph shows the results of our forecasting system for ABBV. You can view historical price data with some markers indicating where our system has been signaling and where the projected targets have been achieved. This demonstrates to what extent our system's forecasts have been justified in real market conditions.

We do not display all the achieved goals on the graph, you can get detailed information about the achieved goals in the corresponding section on this page

Access the ABBV Forecast by QuantWave

Stock ticker: ABBV
Name: ABBVIE INC.
Sector: Healthcare
Investing Risk: LOW
Forecast length: 6 months, 26 days
Accuracy: 61.75 %
Average profit per target: 9.38 %


ABBV Achieves Targets with Precision, as Predicted by QuantWave

Show news about the achieved forecast
Signal Date Signal Price Date Reached Price Reached Profit Direction
2022-05-16138.79 $2024-02-05163.73 $ 17.97%
2022-05-20134.8 $2024-02-05163.73 $ 21.46%
2022-06-10127.83 $2022-11-21143 $ 11.87%
2022-07-01137.29 $2022-08-26122.86 $ 10.52%
2023-01-03147.8 $2024-02-15168.82 $ 14.23%
2023-01-10145.3 $2024-07-25177.4 $ 22.09%
2023-01-17140.43 $2024-02-15168.82 $ 20.22%
2023-02-28141.41 $2024-01-23160.13 $ 13.24%
2023-03-07140.52 $2024-01-23160.13 $ 13.96%
2023-03-21144.05 $2024-01-23160.13 $ 11.17%
2023-03-28145.41 $2024-02-05163.73 $ 12.6%
2023-04-04146.81 $2024-02-06165.67 $ 12.84%
2023-04-11148.28 $2024-02-06165.67 $ 11.72%
2023-04-18147.99 $2024-02-06165.67 $ 11.95%
2023-04-25152.91 $2024-02-15168.82 $ 10.41%
2023-08-01139.27 $2024-01-10156.15 $ 12.12%
2023-08-08140.28 $2024-01-10156.15 $ 11.31%
2023-08-15142.63 $2024-02-15168.82 $ 18.37%
2023-08-22138.99 $2024-02-06165.67 $ 19.2%
2023-09-19143.91 $2024-02-15168.82 $ 17.31%
2023-09-26144.3 $2024-02-15168.82 $ 16.99%
2023-10-03138.23 $2024-02-23170.26 $ 23.17%
2023-10-10139.6 $2024-02-23170.26 $ 21.96%
2023-12-19145.45 $2024-02-05163.73 $ 12.56%
2023-12-26146.42 $2024-02-05163.73 $ 11.82%
2024-01-09153.7 $2024-07-25177.4 $ 15.42%
2024-01-16154.38 $2024-07-25177.4 $ 14.91%
2024-01-23160.13 $2024-07-25177.4 $ 10.78%
2024-01-30157.67 $2024-07-26180.31 $ 14.36%
2024-02-06165.67 $2025-02-27203.14 $ 22.62%
2024-06-25164.76 $2024-08-19191.71 $ 16.36%
2024-07-02160.14 $2024-08-14187.95 $ 17.36%
2024-07-05161.39 $2024-08-19191.71 $ 18.79%
2024-07-16164.77 $2024-09-10194.13 $ 17.82%
2024-07-23168.62 $2024-08-15188.33 $ 11.7%
2024-07-30181.89 $2025-02-27203.14 $ 11.69%
2024-08-13186.22 $2025-03-10214.68 $ 15.28%

Access the ABBV Forecast by QuantWave


The latest news about the achievement of forecasting results and global news about abbvie inc.


ABBVMarch 22, 2025AbbVie ABBV Stock Moves -0.29: What You Should Know  ~1 min.

AbbVie Inc., a renowned pharmaceutical company, has recently experienced a slight decrease in stock movement. As an investor, it is essential to keep track of such fluctuations....

ABBVMarch 20, 2025AbbVie Inc. ABBV is Experiencing Global Investor Interest: A Look into the Company's Success Story  ~2 min.

AbbVie Inc., a renowned pharmaceutical company, has been making waves in the global market, attracting significant attention from investors worldwide....

ABBVMarch 19, 2025AbbVie Inc. ABBV: A Higher-Yielding Healthcare Play That Continues to Shine  ~1 min.

AbbVie Inc., a renowned pharmaceutical company, is steadily gaining the attention of investors. With its continuous success in the healthcare industry, AbbVie has become a top choice for hedge funds....

ABBVMarch 18, 2025The Zacks Analyst Blog Highlights AbbVie, Lockheed Martin, Dell, and Hamilton Beach Brands  ~1 min.

According to a recent analysis by Zacks, AbbVie Inc. (ABBV) is considered one of the top healthcare stocks to invest in....

ABBVMarch 14, 2025AbbVie Inc. ABBV is Attracting Investor Attention: Here is What You Should Know  ~2 min.

AbbVie Inc. (ABBV) has been grabbing the attention of investors recently with its impressive performance in the healthcare sector....

ABBVMarch 10, 2025ABBVIE INC. Hits Price Target Forecast with 15.28% Profit – A Triumph for QuantWave's Analytics  ~1 min.

ABBVIE INC. achieved a significant milestone as it hit the price target forecast set by QuantWave, resulting in a profit of 15.28%....

ABBVFebruary 27, 2025ABBVIE INC. Hits Price Target Forecast with 22.62% Profit Margin  ~1 min.

QuantWave's forecast for ABBVIE INC. proved to be spot on as the stock reached the predicted target with a profitable outcome of 22.62%....

ABBVFebruary 27, 2025ABBVIE INC. Hits QuantWave Price Target with 11.69% Profit Margin  ~1 min.

ABBVIE INC. has successfully reached the price target forecasted by QuantWave, signaling a profitable long position for investors. The forecast, issued on July 30, 2024, at a price of 181....

ABBVFebruary 26, 2025AbbVie Inc. ABBV Announces Innovative Breakthrough in Medical Research  ~2 min.

AbbVie Inc., a renowned pharmaceutical company, has recently announced a groundbreaking discovery in the field of medical research....

ABBVFebruary 24, 2025AbbVie Inc. ABBV Announces 4 Billion Senior Notes Offering  ~2 min.

AbbVie Inc. has recently announced a significant financial move by offering $4 billion in senior notes....




Other QuantWave offers: